Al-Royal Pharmaceutical Private Limited
About Al-Royal Pharmaceutical Private Limited
Data last updated:
Al-Royal Pharmaceutical Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 01 August 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2017PTC321538. Its GSTIN is 07AAPCA8793G1Z1 (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Davinder Kumar Jain and Ramjas Jain.
Its last annual general meeting (AGM) was held on 30 November 2021, and its latest financial statements are for the year ended 31 March 2021. The registered office is at Rzt – 118 First Floor Uttam Nagar Near Chawla Sweet, New Delhi, Delhi, India – 110059.
As per the financials filed for FY 2021, the company reported a revenue of ₹7.21 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.66 Lakh (net margin 0.8%) and EBITDA of ₹7.69 Lakh (EBITDA margin 1.1%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Al-Royal Pharmaceutical Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressRzt – 118 First Floor Uttam Nagar Near Chawla Sweet, New Delhi, Delhi, India – 110059
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Al-Royal Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Al-Royal Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Al-Royal Pharmaceutical Private Limited, buy the company report.
Financials of Al-Royal Pharmaceutical Private Limited
FY 2021 filings availableAl-Royal Pharmaceutical Private Limited reported revenue of ₹7.21 Cr (up 360% YoY) for FY 2021.
Compounded Annual Growth Rate (CAGR)
Revenue rose 360% in the latest year. EBITDA rose 979% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹7.69 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹5.66 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2020-21 | FY 2019-20 | FY 2018-19 | FY 2017-18 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.1% | |||
| Net Profit Margin | 0.8% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Al-Royal Pharmaceutical Private Limited, buy the company report.
Board of directors of Al-Royal Pharmaceutical Private Limited
Al-Royal Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Davinder Kumar Jain | Director | 13 Jun 2019 | 7 Years 4 Months | Current |
| Ramjas Jain Also directs: Excellence Export Private Limited | Director | 01 Aug 2017 | 9 Years 3 Months | Current |
Peer comparison
Al-Royal Pharmaceutical Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Shivsai International Private Limited | ₹7.22 Cr (FY 2025) | 11.0% | New Delhi, Delhi, India | |||
| Convina Research Lab Private Limited | ₹7.22 Cr (FY 2025) | 6.0% | Lucknow, Uttar Pradesh, India | |||
| Al-Royal Pharmaceutical Private Limitedthis company | ₹7.21 Cr (FY 2021) | ₹5.66 Lakh | 0.8% | 360.0% | New Delhi, Delhi, India | |
| Duc Toan Medical (India) Private Limited | ₹7.2 Cr (FY 2025) | 34.0% | New Delhi, Delhi, India | |||
| FG Pharma Private Limited | ₹7.2 Cr (FY 2024) | -17.0% | Chennai, Tamil Nadu, India | |||
| Emedi Pharmaceuticals Private Limited | ₹7.18 Cr (FY 2025) | 37.0% | Patna, Bihar, India |
To see the full peer comparison of Al-Royal Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Al-Royal Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Al-Royal Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Al-Royal Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAPCA8793G1Z1 | Delhi | Active | 21 Sep 2017 |
To see the full GST registrations and return filing status of Al-Royal Pharmaceutical Private Limited, buy the company report.
Recent activity
Al-Royal Pharmaceutical Private Limited has 4 board changes on record since 2017: 3 appointments and 1 cessation. The latest: Davinder Kumar Jain was appointed as Director on 13 Jun 2019.
Frequently asked questions
Al-Royal Pharmaceutical is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 01 August 2017 (9+ years old) and is registered under CIN U24290DL2017PTC321538.
Al-Royal Pharmaceutical has 2 current directors:
- Davinder Kumar Jain - Director
- Ramjas Jain - Director
The latest financial statements of Al-Royal Pharmaceutical on record with the MCA are for the year ended 31 March 2021. Its last annual general meeting was held on 30 November 2021. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Al-Royal Pharmaceutical is 07AAPCA8793G1Z1, registered in Delhi.
The CIN (Corporate Identification Number) of Al-Royal Pharmaceutical is U24290DL2017PTC321538. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Al-Royal Pharmaceutical was incorporated on 01 August 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Al-Royal Pharmaceutical by revenue are Shivsai International Private Limited, Convina Research Lab Private Limited, Duc Toan Medical (India) Private Limited, FG Pharma Private Limited, Emedi Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Davinder Kumar Jain was appointed as Director on 13 Jun 2019. Tawfig S M Elfaghi ceased to be Director on 13 Jun 2019. Ramjas Jain was appointed as Director on 01 Aug 2017. Al-Royal Pharmaceutical has 4 board changes on record in total.
The registered office of Al-Royal Pharmaceutical is at Rzt – 118 First Floor Uttam Nagar Near Chawla Sweet, New Delhi, Delhi, India – 110059.
Al-Royal Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Al-Royal Pharmaceutical is compliant as of 05 August 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
